کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5943546 1574720 2016 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Apolipoprotein E4 association with metabolic syndrome depends on body fatness
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی کاردیولوژی و پزشکی قلب و عروق
پیش نمایش صفحه اول مقاله
Apolipoprotein E4 association with metabolic syndrome depends on body fatness
چکیده انگلیسی


- The human APOE gene is polymorphic and has three alleles, APOE*2, APOE*3 and APOE*4.
- We investigated the association of APOE*4 and metabolic syndrome in two large cohorts (CARDIA, AWHS).
- The presence of the APOE*4 allele increased the prevalence and hazard for MetS.
- Those associations primarily derived from overweight subjects.

Background and aimsThe human Apolipoprotein E (APOE) gene is polymorphic. The APOE*4 allele is a risk factor for cardiovascular disease and could contribute to the development of the metabolic syndrome (MetS) as it may affect all MetS components. We hypothesize that the common APOE4 polymorphism differentially regulates MetS risk and that this association might be modulated by body fatness.Methods & resultsWe used body mass index (BMI) as surrogate of fatness and cross-sectionally studied the prevalence of MetS in 4408 middle-aged men of the Aragon Workers Health Study (AWHS). Our analysis revealed i) a gene dose-dependent association between APOE*4 allele and increased risk for MetS, ii) this association primarily derived from the overweight subjects. For these individuals, the MetS risk was higher in APOE*4 carriers than in non-carriers (Odds Ratio = 1.31; 95% CI, 1.03-1.67).Additionally, we examined 3908 healthy young individuals from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort, followed-up for 25 years. Compared with APOE*4 non-carriers, APOE*4 presence significantly increased the risk of developing MetS (Hazard Ratio, 1.12; 95% CI, 1.00-1.26). Again, an interplay between APOE*4 and the longitudinal development of fatness towards the onset of MetS occurred throughout the study. For individuals with BMI gain below the median, the cumulative onset rate of MetS was significantly higher in APOE*4 carriers than in the non-carriers (HR, 1.29; 95% CI, 1.07-1.55).ConclusionsCarrying APOE*4 alleles increases MetS in a dose-dependent manner, characterizing individual's APOE genotype might help identify at-risk subjects for preventive intervention.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Atherosclerosis - Volume 245, February 2016, Pages 35-42
نویسندگان
, , , , ,